Symbiotec Pharmalab Limited
PrivateLast Round
IPO
Dec 19, 2025
Est. Valuation
$1B
Total Funding Raised
$59.38M
Company Overview
Symbiotec Pharmalab Limited is a pharmaceutical and biotechnology company that specializes in the research, development, and manufacturing of corticosteroid and steroidal-hormone active pharmaceutical ingredients (APIs).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Symbiotec Pharmalab Limited Comparables
Compare Symbiotec Pharmalab Limited with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aarti Pharmalabs Limited | 83% | |
| Axplora | 82% | |
| Tianjin Tianyao Pharmaceuticals Co Ltd | 81% | |
Symbiotec Pharmalab Limited Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Dec 19, 2025 | ||||
| Buyout/LBO | Dec 18, 2018 | ||||
| Private Equity | Oct 22, 2013 | ||||
| Private Equity | Sep 21, 2011 | ||||
| Angel | Jul 1, 2009 | ||||
Angel | Oct 4, 2007 |
Symbiotec Pharmalab Limited Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Motilal Oswal Private Equity | IPO, Buyout/LBO |
| InvAscent | Buyout/LBO |
| Actis | Private Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 20, 2026
Monthly visitors increased 564% MoM.
- May 2, 2025
Monthly visitors increased 32% MoM, reaching 2.9K.
Symbiotec Pharmalab Limited Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |